Limits...
Non-invasive prenatal testing of trisomy 18 by an epigenetic marker in first trimester maternal plasma.

Lee da E, Kim SY, Lim JH, Park SY, Ryu HM - PLoS ONE (2013)

Bottom Line: The maspin (Serpin peptidase inhibitor, clade B (ovalbumin), member 5; SERPINB5) gene, located on chromosome 18q21.33, is hypomethylated in the placenta and completely methylated in maternal blood cells.Median U-maspin concentrations were significantly elevated in women with trisomy 18 fetuses compared with controls (27.2 vs. 6.7 copies/mL; P<0.001).Median M-maspin concentrations were also significantly higher in women with trisomy 18 fetuses than in controls (96.9 vs. 19.5 copies/mL, P<0.001).

View Article: PubMed Central - PubMed

Affiliation: Laboratory of Medical Genetics, Medical Research Institute, Cheil General Hospital and Women's Healthcare Center, Seoul, Korea.

ABSTRACT

Background: Quantification of cell-free fetal DNA by methylation-based DNA discrimination has been used in non-invasive prenatal testing of fetal chromosomal aneuploidy. The maspin (Serpin peptidase inhibitor, clade B (ovalbumin), member 5; SERPINB5) gene, located on chromosome 18q21.33, is hypomethylated in the placenta and completely methylated in maternal blood cells. The objective of this study was to evaluate the accuracy of non-invasive detection of fetal trisomy 18 using the unmethylated-maspin (U-maspin) gene as a cell-free fetal DNA marker and the methylated-maspin (M-maspin) gene as a cell-free total DNA marker in the first trimester of pregnancy.

Methodology/principal findings: A nested case-control study was conducted using maternal plasma collected from 66 pregnant women, 11 carrying fetuses with trisomy 18 and 55 carrying normal fetuses. Median U-maspin concentrations were significantly elevated in women with trisomy 18 fetuses compared with controls (27.2 vs. 6.7 copies/mL; P<0.001). Median M-maspin concentrations were also significantly higher in women with trisomy 18 fetuses than in controls (96.9 vs. 19.5 copies/mL, P<0.001). The specificities of U-maspin and M-maspin concentrations for non-invasive fetal trisomy 18 detection were 96.4% and 74.5%, respectively, with a sensitivity of 90.9%.

Conclusions: Our results suggest that U-maspin and M-maspin concentrations may be useful as potential biomarkers for non-invasive detection of fetal trisomy 18 in the first trimester of pregnancy, irrespective of the sex and genetic variations of the fetus.

Show MeSH

Related in: MedlinePlus

Box plots of U-maspin and M-maspin concentrations in first trimester maternal plasma according to fetal sex.The upper and lower limits of the boxes represent the 75th and 25th percentiles, respectively. The upper and lower whiskers represent the 90th and 10th percentiles, respectively. The median is indicated by the line in each box. Outliers are indicated by circles and extremes by asterisks.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3815335&req=5

pone-0078136-g002: Box plots of U-maspin and M-maspin concentrations in first trimester maternal plasma according to fetal sex.The upper and lower limits of the boxes represent the 75th and 25th percentiles, respectively. The upper and lower whiskers represent the 90th and 10th percentiles, respectively. The median is indicated by the line in each box. Outliers are indicated by circles and extremes by asterisks.

Mentions: We analyzed U-maspin and M-maspin concentrations according to fetal sex. The median concentrations of U-maspin were 6.8 (interquartile range: 3.1–72.6) and 10.6 (interquartile range: 4.7–47.2) copies/mL in women bearing male and female fetuses, respectively. The corresponding concentrations of M-maspin were 19.4 (interquartile range: 3.3–99.1) and 27.1 (interquartile range: 4.5–101.0) copies/mL, respectively. Concentrations of U-maspin and M-maspin were not significantly different between fetal sexes (male and female) (P>0.05 for both) (Fig. 2).


Non-invasive prenatal testing of trisomy 18 by an epigenetic marker in first trimester maternal plasma.

Lee da E, Kim SY, Lim JH, Park SY, Ryu HM - PLoS ONE (2013)

Box plots of U-maspin and M-maspin concentrations in first trimester maternal plasma according to fetal sex.The upper and lower limits of the boxes represent the 75th and 25th percentiles, respectively. The upper and lower whiskers represent the 90th and 10th percentiles, respectively. The median is indicated by the line in each box. Outliers are indicated by circles and extremes by asterisks.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3815335&req=5

pone-0078136-g002: Box plots of U-maspin and M-maspin concentrations in first trimester maternal plasma according to fetal sex.The upper and lower limits of the boxes represent the 75th and 25th percentiles, respectively. The upper and lower whiskers represent the 90th and 10th percentiles, respectively. The median is indicated by the line in each box. Outliers are indicated by circles and extremes by asterisks.
Mentions: We analyzed U-maspin and M-maspin concentrations according to fetal sex. The median concentrations of U-maspin were 6.8 (interquartile range: 3.1–72.6) and 10.6 (interquartile range: 4.7–47.2) copies/mL in women bearing male and female fetuses, respectively. The corresponding concentrations of M-maspin were 19.4 (interquartile range: 3.3–99.1) and 27.1 (interquartile range: 4.5–101.0) copies/mL, respectively. Concentrations of U-maspin and M-maspin were not significantly different between fetal sexes (male and female) (P>0.05 for both) (Fig. 2).

Bottom Line: The maspin (Serpin peptidase inhibitor, clade B (ovalbumin), member 5; SERPINB5) gene, located on chromosome 18q21.33, is hypomethylated in the placenta and completely methylated in maternal blood cells.Median U-maspin concentrations were significantly elevated in women with trisomy 18 fetuses compared with controls (27.2 vs. 6.7 copies/mL; P<0.001).Median M-maspin concentrations were also significantly higher in women with trisomy 18 fetuses than in controls (96.9 vs. 19.5 copies/mL, P<0.001).

View Article: PubMed Central - PubMed

Affiliation: Laboratory of Medical Genetics, Medical Research Institute, Cheil General Hospital and Women's Healthcare Center, Seoul, Korea.

ABSTRACT

Background: Quantification of cell-free fetal DNA by methylation-based DNA discrimination has been used in non-invasive prenatal testing of fetal chromosomal aneuploidy. The maspin (Serpin peptidase inhibitor, clade B (ovalbumin), member 5; SERPINB5) gene, located on chromosome 18q21.33, is hypomethylated in the placenta and completely methylated in maternal blood cells. The objective of this study was to evaluate the accuracy of non-invasive detection of fetal trisomy 18 using the unmethylated-maspin (U-maspin) gene as a cell-free fetal DNA marker and the methylated-maspin (M-maspin) gene as a cell-free total DNA marker in the first trimester of pregnancy.

Methodology/principal findings: A nested case-control study was conducted using maternal plasma collected from 66 pregnant women, 11 carrying fetuses with trisomy 18 and 55 carrying normal fetuses. Median U-maspin concentrations were significantly elevated in women with trisomy 18 fetuses compared with controls (27.2 vs. 6.7 copies/mL; P<0.001). Median M-maspin concentrations were also significantly higher in women with trisomy 18 fetuses than in controls (96.9 vs. 19.5 copies/mL, P<0.001). The specificities of U-maspin and M-maspin concentrations for non-invasive fetal trisomy 18 detection were 96.4% and 74.5%, respectively, with a sensitivity of 90.9%.

Conclusions: Our results suggest that U-maspin and M-maspin concentrations may be useful as potential biomarkers for non-invasive detection of fetal trisomy 18 in the first trimester of pregnancy, irrespective of the sex and genetic variations of the fetus.

Show MeSH
Related in: MedlinePlus